Novanta (NASDAQ:NOVT) Issues FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 3.680-3.740 for the period, compared to the consensus earnings per share estimate of 3.590. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q3 2026 guidance to 0.950-1.000 EPS.

Analysts Set New Price Targets

Several brokerages have recently commented on NOVT. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research report on Saturday. Robert W. Baird set a $180.00 price target on Novanta in a research note on Tuesday, June 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $180.00.

Novanta Price Performance

Shares of Novanta stock traded down $6.37 on Wednesday, hitting $153.12. 548,040 shares of the company traded hands, compared to its average volume of 466,732. Novanta has a 52 week low of $98.27 and a 52 week high of $171.85. The business has a 50-day simple moving average of $153.85 and a 200 day simple moving average of $141.21. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.69 and a current ratio of 3.56. The stock has a market capitalization of $5.78 billion, a P/E ratio of 110.96 and a beta of 1.68.

Novanta (NASDAQ:NOVT) last issued its earnings results on Wednesday, August 5th. The technology company reported $0.89 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.06. The firm had revenue of $265.81 million during the quarter, compared to analyst estimates of $262.30 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. Novanta’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. Research analysts expect that Novanta will post 3.59 earnings per share for the current fiscal year.

Insider Activity at Novanta

In related news, CEO Matthijs Glastra sold 6,500 shares of the business’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total value of $1,047,345.00. Following the sale, the chief executive officer directly owned 29,761 shares in the company, valued at approximately $4,795,389.93. The trade was a 17.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Danske Bank A S purchased a new stake in Novanta during the third quarter valued at $40,000. Van ECK Associates Corp increased its holdings in shares of Novanta by 17.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock worth $163,000 after buying an additional 239 shares during the last quarter. O Shaughnessy Asset Management LLC bought a new stake in shares of Novanta in the 4th quarter worth about $219,000. EntryPoint Capital LLC purchased a new stake in shares of Novanta during the 4th quarter valued at about $261,000. Finally, Corient Private Wealth LLC purchased a new stake in shares of Novanta during the 4th quarter valued at about $275,000. 98.35% of the stock is currently owned by institutional investors.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.